The Trump approach to the economy is anything but conservative, write Yale SOM’s Jeffrey Sonnenfeld, former Procter & Gamble ...

Medtronic shows mixed results with strong Cardiovascular growth and weaker Neuroscience/MedSurg. Click here to read an ...

Truist raised the firm’s price target on Medtronic (MDT) to $96 from $92 and keeps a Hold rating on the shares. The company’s in-line Q1 organic ...

The use of robotics in surgery is on the rise. The market was valued at $800 million in 2015, and has since risen to over $3 ...

Citi analyst Joanne Wuensch raised the firm’s price target on Medtronic (MDT) to $101 from $99 and keeps a Buy rating on the shares. The firm ...

A clutch of post-earnings price target increases by analysts helped raise Medtronic 's (NYSE: MDT) stock at a healthy rate on ...

The S&P 500 declined 0.2% on Wednesday, Aug. 20, 2025, as tech stocks slid and minutes from the latest Federal Reserve ...

Medtronic has appointed John Groetelaars and Bill Jellison to its board as independent directors, effective immediately, and formed two board committees.

Medtronic posted better-than-expected earnings, lifted its sales forecast, and faces analyst debate on growth prospects and ...

Even great businesses go through hard times, which is why you'll want to look at this medical device maker and this ...